News | June 04, 2022
Innate Pharma announces IPH5201 phase 2 study in lung cancer
Innate to receive $5M milestone payment from AstraZeneca
Innate to receive $5M milestone payment from AstraZeneca
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
